Does MOLSIDOMINE Cause Left ventricular hypertrophy? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Left ventricular hypertrophy have been filed in association with MOLSIDOMINE. This represents 2.4% of all adverse event reports for MOLSIDOMINE.
9
Reports of Left ventricular hypertrophy with MOLSIDOMINE
2.4%
of all MOLSIDOMINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Left ventricular hypertrophy From MOLSIDOMINE?
Of the 9 reports.
Is Left ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLSIDOMINE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does MOLSIDOMINE Cause?
Toxic epidermal necrolysis (84)
Blister (54)
Erythema (53)
Nausea (48)
Multiple organ dysfunction syndrome (45)
Respiratory disorder (44)
Diarrhoea (41)
Hypertension (37)
Cholecystitis (36)
Electrolyte imbalance (36)
What Other Drugs Cause Left ventricular hypertrophy?
AMLODIPINE (158)
CLOZAPINE (149)
TACROLIMUS (135)
FUROSEMIDE (128)
PANTOPRAZOLE (117)
BISOPROLOL (114)
SACUBITRIL\VALSARTAN (105)
ASPIRIN (104)
ROSUVASTATIN (94)
CARVEDILOL (87)
Which MOLSIDOMINE Alternatives Have Lower Left ventricular hypertrophy Risk?
MOLSIDOMINE vs MOMELOTINIB
MOLSIDOMINE vs MOMETASONE
MOLSIDOMINE vs MOMETASONE FUROATE
MOLSIDOMINE vs MOMETASONE FUROATE\OLOPATADINE
MOLSIDOMINE vs MONOMETHYL